Active Versus Conventional Side Branch Protection Strategy for Coronary Bifurcation Lesions

Qiao Qin1, Bo Zheng1, Jiahui Liu1

  • 1Department of Cardiology, Institute of Cardiovascular Disease, Peking University First Hospital.

International Heart Journal
|November 18, 2021
PubMed

Insights

Active side branch protection (SB-P) in coronary bifurcation stenting reduces side branch occlusion. However, this strategy does not decrease periprocedural myocardial infarction or improve long-term outcomes compared to conventional methods.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Medical Device Technology

Background:

  • The provisional stenting strategy is standard for coronary bifurcation lesions.
  • Side branch (SB) deterioration can lead to periprocedural myocardial infarction (PMI) and affect long-term prognosis.
  • Various side branch protection (SB-P) techniques aim to mitigate SB occlusion.

Purpose of the Study:

  • To compare the outcomes of active SB-P techniques (jailed balloon, balloon-stent kissing, jailed Corsair) versus conventional jailed wire technique.
  • To evaluate the impact of active SB-P on SB occlusion, PMI, and major adverse cardiovascular events (MACE).

Main Methods:

  • Meta-analysis of 5 studies (4 randomized, 1 observational) with 1,174 patients.
  • Comparison of active SB-P versus conventional SB-P strategies.
  • Use of fixed- and random-effects models to calculate summary risk ratios (RRs).

Main Results:

  • Active SB-P significantly reduced the risk of SB occlusion (RR 0.47-0.52).
  • No significant difference was observed in the risk of PMI between active and conventional SB-P (RR 0.63-0.71).
  • Long-term MACE rates were similar across both strategies (RR 0.48-0.49).

Conclusions:

  • Active SB-P strategies effectively reduce side branch deterioration during coronary bifurcation stenting.
  • Despite reduced SB occlusion, active SB-P does not significantly decrease periprocedural myocardial infarction or improve long-term cardiovascular outcomes.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
63
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
79